Continuous Positive Airway Pressure (CPAP) Devices Market Summary

The global continuous positive airway pressure devices market size was estimated at USD 1,902.6 million in 2024 and is projected to reach USD 2,616.1 million by 2030, growing at a CAGR of 5.45% from 2025 to 2030. This growth is largely attributed to the increasing prevalence of sleep apnea worldwide, the growing emphasis on preventive healthcare, and the rapidly advancing healthcare infrastructure, particularly in emerging economies. These factors collectively contribute to rising awareness, early diagnosis, and the widespread adoption of Continuous Positive Airway Pressure (CPAP) devices as a primary treatment option.

The rising supportive initiatives from government bodies and private organizations for Continuous Positive Airway Pressure devices represent a notable trend expected to further propel market expansion. Awareness campaigns, reimbursement support, and improved access to respiratory care solutions are encouraging more patients to seek timely intervention. Additionally, the significant rise in preference for home-based healthcare solutions, along with the growing integration of remote monitoring capabilities, is boosting market growth.

As healthcare systems shift from conventional hospital-based care toward decentralized, patient-centric models, the demand for technologies that support home care continues to accelerate. In this context, sleep apnea devices are increasingly used for home-based noninvasive ventilation therapy to provide continuous respiratory support for patients outside clinical settings.

CPAP devices serve as a cost-effective and convenient alternative to traditional care by allowing individuals to receive appropriate respiratory therapy within their homes. This leads to reduced hospitalization rates, improved treatment adherence, and enhanced patient comfort. As more healthcare providers and consumers recognize these benefits, the adoption of CPAP devices continues to rise across various regions.

Key Market Trends & Insights

• North America held the largest revenue share of 42.29% in 2024, supported by high diagnosis rates, improved access to sleep specialists, and strong reimbursement structures.
• The CPAP devices market in Asia Pacific is expected to witness the fastest growth over the forecast period owing to rising awareness, urbanization, increasing healthcare investments, and a growing patient pool susceptible to sleep disorders.
• In terms of end use, the home care settings segment accounted for the largest revenue share of over 59.00% in 2024, reflecting the strong transition toward home-based therapies.
• In terms of connectivity, the connected CPAP devices segment held the largest revenue share of over 68.00% in 2024, driven by the demand for real-time monitoring and data-driven treatment adjustments.

Order a free sample PDF of the Continuous Positive Airway Pressure (CPAP) Devices Market Intelligence Study, published by Grand View Research.

Market Size & Forecast

• 2024 Market Size: USD 1,902.6 Million
• 2030 Projected Market Size: USD 2,616.1 Million
• CAGR (2025-2030): 5.45%
• North America: Largest market in 2024
• Asia Pacific: Fastest growing market

Key Companies & Market Share Insights

The market is highly consolidated, with large players and emerging players operating in this space adopting various strategies such as collaborations, acquisitions, partnerships, and launching new devices. Some emerging players in the market include Transcend Inc. (Somnetics International, Inc.) and React Health (3B Medical).

Key Players

• ResMed
• Koninklijke Philips N.V.
• Fisher & Paykel Healthcare Limited
• Medical Depot, Inc. dba Drive DeVilbiss Healthcare
• React Health (3B Medical)
• Transcend Inc. (Somnetics International, Inc.)
• Wellell Inc. (Apex Medical)
• BMC

Explore Horizon Databook – The world's most expansive market intelligence platform developed by Grand View Research.

Conclusion

The global CPAP devices market is poised for steady expansion as awareness of sleep apnea continues to rise and healthcare systems increasingly adopt decentralized care models. Technological advancements, such as remote monitoring and connected device capabilities, are transforming patient management and improving treatment adherence. Government and private sector initiatives are further enhancing accessibility to respiratory care solutions, especially within home care environments. With strong growth prospects in emerging economies and increasing emphasis on preventive health, CPAP devices are becoming an essential component of long-term respiratory therapy. These trends collectively indicate a positive outlook for sustained industry growth through 2030.